Evaluation of a Human Immunodeficiency Virus (HIV) Blood Screening Assay

PHASE3CompletedINTERVENTIONAL
Enrollment

24,111

Participants

Timeline

Start Date

August 31, 2007

Primary Completion Date

August 31, 2008

Study Completion Date

August 31, 2008

Conditions
Healthy DonorsHIV Positive
Interventions
DEVICE

collection of follow-up sample based on PRISM HIV O Plus result

Test blood samples with investigational HIV assay. If results are reactive, donors may be deferred and asked to return for a follow-up blood draw.

Trial Locations (7)

19123

American Red Cross, Philadelphia

38134

Interstate Blood Bank, Inc., Memphis

45402

Community Blood Center, Dayton

52807

Mississippi Valley Regional Blood Center, Davenport

64111

Community Blood Center of Greater Kansas City, Kansas City

78201

South Texas Blood And Tissue Center, San Antonio

98057

Puget Sound Blood Center, Renton

All Listed Sponsors
lead

Abbott Diagnostics Division

INDUSTRY

NCT00686205 - Evaluation of a Human Immunodeficiency Virus (HIV) Blood Screening Assay | Biotech Hunter | Biotech Hunter